Key Takeaway
Detailed comparison of MEDVi and Hers GLP-1 weight loss programs for 2026. Which telehealth platform is the better choice for women?
Bottom line: Hers has the edge for women who want a simplified, affordable GLP-1 experience wrapped in a brand built specifically for them. The platform is designed with women's health in mind, and its pricing runs lower than MEDVi's. MEDVi counters with a more clinical, physician-led approach and deeper health monitoring. For most women seeking straightforward compounded GLP-1 therapy, Hers delivers a better overall package. For women with complex health profiles who want thorough medical oversight, MEDVi earns a closer look.
Quick Comparison
| Feature | MEDVi | Hers |
|---|---|---|
| Monthly cost | $249-$399/mo | $199-$349/mo |
| Consultation fee | Included | Included |
| Medications offered | Compounded semaglutide, tirzepatide | Compounded semaglutide, tirzepatide (when available) |
| Target audience | General adult population | Women |
| Provider type | Board-certified physicians | Licensed providers (MDs, NPs, PAs) |
| Lab work | thorough panel included | Varies by state and plan |
| App experience | Basic patient portal | Polished app designed for women |
| Additional services | Metabolic health tracking | Broader women's health offerings (skin, hair, mental health) |
| Shipping | Free standard | Free |
| States available | 30+ | Most U.S. states |
Pricing Breakdown
Hers comes in at a lower price point, with compounded semaglutide starting around $199/month. MEDVi starts closer to $249/month. At the higher end, both platforms charge in the $350-$400 range for tirzepatide options or higher-dose semaglutide protocols.
View data table
| Category | Overall Value Score | Detail |
|---|---|---|
| FormBlends | 92 | From $299/mo, physician-led |
| Hims/Hers | 78 | Consumer brand, varies |
| Ro | 75 | Telehealth platform |
| Calibrate | 70 | Metabolic health focus |
The price difference largely reflects what each platform bundles into the package. MEDVi includes thorough metabolic bloodwork, which adds clinical depth but drives up cost. Hers keeps the focus tighter on medication and provider access, which is reflected in the lower starting price.
For women who already have a gynecologist or primary care physician ordering regular labs, the Hers approach avoids duplicating services. For women who don't have an existing provider running metabolic panels, MEDVi's included lab work could actually be a bargain compared to ordering those tests independently.
Medications Available
Both platforms prescribe compounded semaglutide as their main GLP-1 option. Compounded tirzepatide is available at both when supply allows, though availability has been unpredictable across the entire telehealth industry.
Not sure which GLP-1 is right for you?
Take a 2-minute assessment and get a personalized recommendation after licensed provider review.
Take the Assessment →Hers benefits from the same pharmacy infrastructure as Hims (they operate under the same parent company, Hims & Hers Health). This gives Hers access to a larger compounding pharmacy network, which generally translates to more reliable supply and faster fulfillment.
MEDVi works with a smaller set of compounding partners. The upside is potentially tighter quality oversight. The downside is that during supply crunches, MEDVi patients may experience longer wait times.
Neither platform is a consistent option for brand-name GLP-1 medications like Wegovy or Mounjaro.
Patient Experience
Hers wins on design and usability. The app is clean, intuitive, and built with women in mind. Everything from onboarding to refills to provider messaging is handled in a single interface. The content and educational materials within the app are also tailored to women's health contexts, which matters when discussing side effects, hormonal interactions, and weight loss expectations.
MEDVi's portal is more utilitarian. It does the job, but it lacks the design polish and women-specific content that Hers provides. What MEDVi does offer is a more involved intake process, with longer initial consultations and more detailed health history reviews.
Women who value a platform that speaks directly to their health concerns will find Hers more comfortable. Women who prioritize clinical thoroughness over design may appreciate MEDVi's approach.
Provider Quality and Support
MEDVi staffs its consultations with board-certified physicians. Hers uses a mix of MDs, NPs, and PAs, all licensed in the patient's state. Both models are medically sound for GLP-1 prescribing.
One area where Hers adds value is its integration of weight loss with other women's health services. If you're also dealing with hormonal acne, hair thinning, or mood changes, Hers can address multiple concerns under one roof. MEDVi is more narrowly focused on metabolic health and weight management.
For support responsiveness, Hers offers broader hours and faster initial reply times, consistent with the Hims & Hers infrastructure. MEDVi's responses tend to be more detailed but slower.
Pros and Cons
MEDVi
Pros:
- Physician-led consultations
- thorough lab work included
- Structured metabolic health protocols
- Detailed, personalized provider communication
Cons:
- Higher pricing
- Less polished digital experience
- Not specifically designed for women's health
- Smaller pharmacy network
Hers
Pros:
- Lower monthly pricing
- Purpose-built for women
- Excellent app experience
- Can bundle other women's health treatments
- Large provider and pharmacy network
Cons:
- Provider interactions can feel quick or scripted
- Lab work not always included
- Less clinical depth in initial assessments
- High volume can dilute personalization
Who Should Choose MEDVi
MEDVi is the better choice for women who have complex health histories, want thorough bloodwork as part of their weight loss program, or prefer working directly with a physician rather than a mixed provider team. If you value clinical rigor over convenience, MEDVi delivers.
Who Should Choose Hers
Hers is the better choice for most women who want affordable, convenient GLP-1 therapy on a platform designed for them. The lower price, better app, and ability to bundle other health services make Hers the more practical option for healthy women seeking straightforward treatment.
How FormBlends Compares
FormBlends offers physician-supervised telehealth that combines GLP-1 weight loss medication with peptide wellness therapy. Like MEDVi, every FormBlends patient works with a licensed physician. But FormBlends goes further by offering peptide protocols for recovery, energy, and metabolic support that neither MEDVi nor Hers currently provide. Women looking for a thorough, physician-led approach that extends beyond just a GLP-1 prescription can learn more at FormBlends.com.
Frequently Asked Questions
Is Hers just Hims rebranded for women?
Not exactly. Hers is operated by the same parent company (Hims & Hers Health) and shares infrastructure, but its content, provider training, and product selection are tailored specifically for women. The GLP-1 medications are the same, but the surrounding experience is designed differently.
Does MEDVi offer anything specific for women's health?
MEDVi's metabolic health approach benefits anyone, but the platform isn't specifically designed around women's health concerns. It doesn't offer the bundled services (skin, hair, mental health) that Hers provides.
Which platform ships faster?
Hers typically ships faster due to its larger pharmacy network. Most Hers orders arrive within 3-5 business days. MEDVi averages 5-7 business days, though this can vary with supply conditions.
Can I switch between platforms easily?
Yes. Neither platform locks you into a long-term contract. You can cancel and enroll elsewhere, though you'll need to go through the new platform's intake and consultation process from scratch.
Interested in physician-supervised GLP-1 therapy paired with peptide wellness protocols? See how FormBlends works and decide if it's right for you.